Tetsuya Kajimoto

The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β

Masayoshi Tojo, Yoshio Hamashima, Aki Hanyu et al. · Cancer Science · 2005 · 354 citations · Full text

Life Sciences, Oncology, Pharmacology +16

Sophoranone, extracted from a traditional Chinese medicine <i>Shan Dou Gen,</i> induces apoptosis in human leukemia U937 cells via formation of reactive oxygen species and opening of mitochondrial permeability transition pores

Sachiko Kajimoto, Noriko Takanashi, Tetsuya Kajimoto et al. · International Journal of Cancer · 2002 · 68 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

A Novel Transforming Growth Factor β Receptor Kinase Inhibitor, A-77, Prevents the Peritoneal Dissemination of Scirrhous Gastric Carcinoma

Hidemi Kawajiri, Masakazu Yashiro, Osamu Shinto et al. · Clinical Cancer Research · 2008 · 38 citations

Medicine, Oncology, Pharmacology +17

Intra-articular oxidative state correlated with the pathogenesis of disorders of the temporomandibular joint

Mihoko Tomida, Jun-Ichi Ishimaru, K. Murayama et al. · British Journal of Oral and Maxillofacial Surgery · 2004 · 25 citations

Dentistry, Temporomandibular Disorders, Temporomandibular Disorder Epidemiology +9

Effects of disialoganglioside GD3 on the mitochondrial membrane potential

Yu Higuchi, Tsuyoshi Miura, Tetsuya Kajimoto et al. · FEBS Letters · 2005 · 23 citations

Life Sciences, Biochemistry, Cell Biology +14